Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.
Biomarkers and Early Predictors of Prognostic Course, Response to Possible to Possible Treatments and Risk of Over-infection in Patients With COVID-19 Hospitalized in the Critical or Semi-intensive Area.
Sponsor: University of Turin, Italy
Listed as NCT04873388, this observational or N/A phase trial focuses on C-reactive Protein and Covid19 and remains ongoing. Sponsored by University of Turin, Italy, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Aug 2025 — Present [monthly]
Unknown
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Sep 2023 — Jul 2024 [monthly]
Enrolling By Invitation
-
Jun 2023 — Sep 2023 [monthly]
Enrolling By Invitation
▶ Show 3 earlier versions
-
Jun 2022 — Jun 2023 [monthly]
Enrolling By Invitation
-
Dec 2021 — Jun 2022 [monthly]
Enrolling By Invitation
-
Jun 2021 — Dec 2021 [monthly]
Enrolling By Invitation
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Turin, Italy
For direct contact, visit the study record on ClinicalTrials.gov .